Principal Financial Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Principal Financial Group’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,414	Closed	-$212K	–	2415
2020 Q1	$212K	Sell	4,414 -98	-2%	-$4.56K	﹤0.01%	2052
2019 Q4	$212K	Buy	+4,512	New	+$199K	﹤0.01%	2127

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Principal Financial Group's RARX Position: Q2 2020 in Review

Principal Financial Group sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 4,414 shares — an estimated $212K sold.

Principal Financial Group first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $212K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Principal Financial Group reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Principal Financial Group sold 4,414 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $212K.
Principal Financial Group first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Principal Financial Group's Ra Pharmaceuticals, Inc. Common Stock position peaked at $212K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Principal Financial Group's 13F filing for Q2 2020, filed 5 Aug 2020.